Michael Wyzga, Director at Exact Sciences, holds 11.47K shares in Exact Sciences (Ticker: EXAS), holds ― shares in Logicbio Therapeutics (Ticker: LOGC), holds ― shares in X4 Pharmaceuticals (Ticker: XFOR).
Michael Wyzga latest transaction was an Uninformative Buy of ―.
What was Michael Wyzga's most profitable transaction?
Michael Wyzga’s most profitable transaction was an Informative Buy of AKBA stock on March 27, 2014. The return on the trade was -46.10%.
What is Michael Wyzga's role in Exact Sciences?
Michael Wyzga's role in Exact Sciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.